Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Vizio Clinical Study: A Prospective, Multicenter, Feasibility Clinical Study to Evaluate the Safety and Efficacy of the Vizio Aqueous Microshunt for the Treatment of Refractory Glaucoma

NCT06591117 is registered in ClinicalTrials.gov with Ocumedex as lead sponsor.

NCT NCT06591117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06591117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Vizio Clinical Study: A Prospective, Multicenter, Feasibility Clinical Study to Evaluate the Safety and Efficacy of the Vizio Aqueous Microshunt for the Treatment of Refractory Glaucoma
Lead sponsor
Ocumedex
Phase
Not applicable
Overall status
Recruiting
Start date
March 21, 2026
Completion date
March 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory glaucoma